COMMUNIQUÉS West-GlobeNewswire
-
Lirum Therapeutics Announces FDA “Study May Proceed” Letter Enabling Inclusion of LX-101 in the RAPID Platform Clinical Trial for Ewing Sarcoma and Desmoplastic Small Round Cell Tumor
20/10/2025 -
Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025
20/10/2025 -
BrightSpring Announces Secondary Offering of Common Stock and Concurrent Share Repurchase
20/10/2025 -
Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder
20/10/2025 -
BrightSpring Health Services, Inc. Reports Preliminary Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance
20/10/2025 -
SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025
20/10/2025 -
CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer
20/10/2025 -
Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union
20/10/2025 -
Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares in the Public Offering
20/10/2025 -
Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene Therapy
20/10/2025 -
Anresco Laboratories and NJ Labs Unite to Form Nationwide Testing Network Built on Trusted, Proven Expertise
20/10/2025 -
Noom Launches AI Face Scan and AI Future Me to Bring Preventive Health Insights to Everyone
20/10/2025 -
ThrIVe Health Announces Patient Education Seminar Featuring Leading Thyroid Eye Disease Specialist Dr. Raymond Douglas
20/10/2025 -
IMPALA Appoints Ann Marie Dunne as New Chair, Succeeding Jonathan Taylor
20/10/2025 -
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025 -
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025 -
Immatics Highlights Compelling Anti-Tumor Activity of Anzu-cel PRAME Cell Therapy in Metastatic Uveal Melanoma at the ESMO 2025 Presidential Symposium
20/10/2025 -
KFSHRC Performs World’s First Robotic Intracranial Tumor Resection ... A New Era in Neurosurgery
20/10/2025 -
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
20/10/2025
Pages